Bath & Body Works Hits 52-Week Low at $24.81 Amidst Declining Performance

Bath & Body Works, Inc. has reached a new 52-week low, trading at USD 24.81 as of October 29, 2025. This marks a significant decline for the small-cap company, which operates within the footwear industry. Over the past year, Bath & Body Works has experienced a notable decrease in its stock price, reflecting a performance drop of 45.41%, contrasting sharply with the S&P 500's gain of 18.33% during the same period.
The company's market capitalization stands at USD 6,299 million, and it currently has a price-to-earnings (P/E) ratio of 7.00. However, Bath & Body Works is facing challenges, including a negative book value and a return on equity that is significantly low. The firm has reported a decline in net sales at an annual rate of 8.28% and a modest operating profit growth of 8.12% over the last five years.

Additionally, the company has shown a concerning trend in its financial metrics, with a cash and equivalents figure of USD 1,000 million and an inventory turnover ratio of 4.44 times. These indicators suggest that Bath & Body Works is navigating a difficult financial landscape, contributing to its recent stock performance.